Experts say RFK Jr. could play big role in Trump 2.0, FDA leadership to face scrutiny

Regulatory NewsRegulatory NewsDiagnostics/IVDsGovernment/legislationLeadershipMedical DevicesPharmaceuticalsRegulatory Intelligence/PolicyUnited StatesUS Food and Drug Administration (FDA)